PDK4-IN-1 hydrochloride
- CAS No.
- 2310262-11-2
- Chemical Name:
- PDK4-IN-1 hydrochloride
- Synonyms
- PDK4-IN-1 HCl;PDK4-IN-1 hydrochloride;PDK4-IN-1 hydrochloride, 10 mM in DMSO;1-(1-(Piperidin-4-yl)-1H-pyrazol-4-yl)anthracene-9,10-dione hydrochloride;inhibit,anti-allergic,Pyruvate dehydrogenase kinase,PDHE1α,antidiabetic,p53,BCL-xL,PARP1,caspase-3,BAX,Inhibitor,p-Akt,Apoptosis,PDK4,PDK4 IN 1 hydrochloride,PDK4IN1 hydrochloride,PDK-4-IN-1 hydrochloride,PDHK,metabolites,PDH kinase,anticancer
- CBNumber:
- CB98044775
- Molecular Formula:
- C22H20ClN3O2
- Molecular Weight:
- 393.87
- MDL Number:
- MFCD32671322
- MOL File:
- 2310262-11-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Pdk4-in-1 hydrochloride | KSD26211 | 10mg | $806.9 |
| Pdk4-in-1 hydrochloride | KSD26211 | 25mg | $1316 |
| Pdk4-in-1 hydrochloride | KSD26211 | 50mg | $2105 |
| PDK4-IN-1 hydrochloride 99.72% | CS-0116441 | 5mg | $213 |
| PDK4-IN-1 hydrochloride 99.72% | CS-0116441 | 10mg | $316 |
| storage temp. | Inert atmosphere,Room Temperature |
|---|---|
| solubility | DMSO: 125 mg/mL (317.36 mM) |
| form | Solid |
| color | Light yellow to yellow |
| Water Solubility | H2O: 2mg/mL, clear (Warmed) |
| InChIKey | ZIMLKZKPNALXKK-UHFFFAOYSA-N |
| SMILES | Cl.[n]2(ncc(c2)c3c4c(ccc3)C(=O)c5c(cccc5)C4=O)C1CCNCC1 |
| UNSPSC Code | 12352200 |
| NACRES | NA.21 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| WGK Germany | WGK 3 |
| Storage Class | 11 - Combustible Solids |
PDK4-IN-1 hydrochloride price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | KSD26211 | Pdk4-in-1 hydrochloride | 2310262-11-2 | 10mg | $806.9 | 2026-06-04 | Buy |
| Biosynth | KSD26211 | Pdk4-in-1 hydrochloride | 2310262-11-2 | 25mg | $1316 | 2026-06-04 | Buy |
| Biosynth | KSD26211 | Pdk4-in-1 hydrochloride | 2310262-11-2 | 50mg | $2105 | 2026-06-04 | Buy |
| ChemScene | CS-0116441 | PDK4-IN-1 hydrochloride 99.72% | 2310262-11-2 | 5mg | $213 | 2026-06-04 | Buy |
| ChemScene | CS-0116441 | PDK4-IN-1 hydrochloride 99.72% | 2310262-11-2 | 10mg | $316 | 2026-06-04 | Buy |
PDK4-IN-1 hydrochloride Chemical Properties,Uses,Production
Uses
PDK4-IN-1 hydrochloride is an anthraquinone derivative and a potent and orally active pyruvate dehydrogenase kinase 4 (PDK4) inhibitor with an IC50 value of 84 nM. PDK4-IN-1 hydrochloride potently represses cellular transformation and cellular proliferation and induces apoptosis. PDK4-IN-1 hydrochloride has antidiabetic, anticancer and anti-allergic activity[1].
Biological Activity
PDK4-IN-1 hydrochloride is an anthraquinone derivative and a potent, orally active inhibitor of pyruvate dehydrogenase kinase 4 (PDK4) with IC50 of 84 nM. It effectively inhibits cell transformation and cell proliferation and induces apoptosis. It has antidiabetic, anticancer and antiallergic effects.
in vitro
PDK4-IN-1 (Compound 8c; 50 μM; 0-72 hours; HCT116 and RKO cells) treatment significantly impedes the proliferation of human colon cancer cell lines, HCT116 and RKO. The colony formation efficiency in HCT116 and RKO cells Is significantly reduced after treatment of PDK4-IN-1.
PDK4-IN-1 (Compound 8c; 10-50 μM; 24 hours; HCT116 and RKO cells) treatment dose-dependently increased apoptosis.
PDK4-IN-1 (Compound 8c; 10 μM; 24 hours; HEK293T cells) treatment inhibits phosphorylation of Ser 232 , Ser 293 , and Ser 300 of PDHE1α.
10 μM of PDK4-IN-1 (Compound 8c) significantly increased p-Akt in AML12 cells.
PDK4-IN-1 (compound 8c)-induced phosphorylation of p53 on serine 15 is a dose-dependent response in both HCT116 and RKO cells. PDK4-IN-1 decreases the expression of BCL-xL and increases the expression of BAX. Cleavage of PARP1 and caspase 3 are increased by PDK4-IN-1.
Cell Viability Assay
| Cell Line: | HCT116 and RKO cells |
| Concentration: | 50 μM |
| Incubation Time: | 0 hour, 24 hours, 48 hours, 72hours | td>
| Result: | Significantly impeded the proliferation of human colon cancer cell lines, HCT116 and RKO. |
Apoptosis Analysis
| Cell Line: | HCT116 and RKO cells |
| Concentration: | 10 μM, 25 μM, 50 μM |
| Incubation Time: | < td class="col2"> 24 hours|
| Result: | Dose-depend ently increased apoptosis. |
Western Blot Analysis < /p>
| Cell Line: | HEK293T human embryonic kidney cells |
| Concentration: | 10 μM |
| Incubation Time: < /td> | 24 hours |
| Result: | Inhibited phosphorylation of Ser 232 , Ser 293 , and Ser 300 of PDHE1α. |
in vivo
PDK4-IN-1 (Compound 8c; 100 mg/kg; oral administration; daily; for 1 week; C57BL/6J mice) treatment significantly improves glucose tolerance.
Pre-incubation with it (compound 8c) dose-dependently inhibits the release of β-hexosaminidase from IgE/antigen-activated BMMCs, showing that the absorbance values are 0.26, 0.20, and 0.126 in IgE/Ag, 10 μM, and 20 μM PDK4- IN-1-treated BMMCs.
The pharmacokinetic (PK) profiles of PDK4-IN-1 (compound 8c) are evaluated in rat. PDK4-IN-1 shows good bioavailability (64%), long half-life ( >7 h), and moderate clearance (CL of 0.69) in rats.
| Animal Model: | C57BL/6J mice (8 -week old) fed with high-fat diet |
| Dosage: | 100 mg/kg | td>
| Administration: | Oral adminis tration; daily; for 1 week |
| Result: | Significantly improved glucose tolerance. |
target
IC50: 84 nM (Pyruvate dehydrogenase kinase 4 (PDK4))
References
[1] Lee D, et al. Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases. J Med Chem. 2019 Jan 24;62(2):575-588. DOI:10.1021/acs.jmedchem.8b01168
PDK4-IN-1 hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
PDK4-IN-1 hydrochloride Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 38999 | 58 |
| Shaanxi Dideu New Materials Co. Ltd | 18192503167 | 1036@dideu.com | China | 13339 | 58 |
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Bide Pharmatech Ltd. | 400-164-7117 18317119277 | product02@bidepharm.com | China | 40000 | 60 |
| Shanghai Beckham Medical Technology Co., Ltd | 13816613772 | huahero21@sina.com | China | 2997 | 55 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Shanghai Rechem science Co., Ltd. | 021-31433387 15618786686 | sales@rechemscience.com | China | 2972 | 58 |
| MQ (shanghai) Pharmaceuticals Co., Ltd. | 13761635123 | sales@linyuepharm.com | China | 5731 | 55 |
| Changzhou Chenhong Biotechnology Co., Ltd. | +86-0519-85788828 +86-13775037613 | sales@chemrenpharm.com | China | 4058 | 58 |
View Lastest Price from PDK4-IN-1 hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-22 | PDK4-IN-1 hydrochloride
2310262-11-2
|
1KG | 98% | 1000kg | Shaanxi Dideu New Materials Co. Ltd | ||
![]() |
2026-07-15 | PDK4-IN-1 hydrochloride
2310262-11-2
|
$67.00-238.00 | 99.67% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-15 | PDK4-IN-1 hydrochloride
2310262-11-2
|
$67.00-238.00 | 99.67% | 10g | TargetMol Chemicals Inc. |
-

- PDK4-IN-1 hydrochloride
2310262-11-2
- $0.00
- 98%
- Shaanxi Dideu New Materials Co. Ltd
-

- PDK4-IN-1 hydrochloride
2310262-11-2
- $67.00-238.00
- 99.67%
- TargetMol Chemicals Inc.
-

- PDK4-IN-1 hydrochloride
2310262-11-2
- $67.00-238.00
- 99.67%
- TargetMol Chemicals Inc.





